Povan

   
Google
 
Web NewDrugInformation.com

Povan


Drug - Povan
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Pyrvinium Pamoate
Multiple ingredients are in alphabetical order.

Strength - EQ 50MG BASE
The potency of the active ingredient(s), Pyrvinium Pamoate. May repeat for multiple part products.

Applicant - PARKE DAVIS
The firm name holding legal responsibility for Povan. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 012485
The FDA assigned number to Povan. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Povan. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Povan was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Povan. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Povan is in. Format is RX, OTC, DISCN.

Applicant Full Name - Parke Davis Div Warner Lambert Co
The full name of the firm holding legal responsibility for the new application of Povan.

Povan